Note: the following material is for personal use only see below for



Download 3.95 Mb.
Page24/73
Date30.04.2018
Size3.95 Mb.
#47014
1   ...   20   21   22   23   24   25   26   27   ...   73

Lung Cancer



Presentation: fever, chest pain, weight loss, fatigue, weakness, decreased activity, worsening cough, dyspnea, decreased appetite, weight loss, and pain / malignant serosanguineous pleural effusions are common and are often large and recurrent.

Diagnosis (also see SPN below) [NEJM]

  • CXR (mass, effusion) bronchial narrowing and irregularity, parenchymal infiltration, or atelectasis. Cavitation may be visible in an obstructed area or within a peripheral tumor. Pleural effusions are often associated with infiltrating or peripheral tumors

  • thoracentesis (60% yield in NSCLC; would be IIIB T4) / pH usu. > 7.3 (< 7.2 worse prognosis) / WBC < 4000 cells/mm3 (< 25% neutrophils; more suggests infection)

  • CT (chest, head, liver)

  • bronchoscopy

  • MRI (its role is evolving)

  • CT (still debated whether screening is beneficial or cost-effective 3/07)

  • bone scan

  • LFT

  • bronchial biopsy, washings

  • mediastinoscopy with lymph node biopsy

  • exploratory thoracotomy required in < 10% of cases to establish the diagnosis (if any evidence of mets, probably no benefit; such as lymph nodes, skin, liver, pleura)

  • Ddx: foreign bodies, nonsegmental pneumonia, endobronchial and focal pulmonary manifestations of TB, systemic mycoses, autoimmune disease, metastatic disease caused by an extrathoracic primary cancer. Solitary pulmonary nodules are difficult to differentiate.

Metastases to the lungs are common from primary cancers of the breast, colon, prostate, kidney, thyroid, stomach, cervix, rectum, testis, bone and melanoma

Treatment: radiation / chemotherapy (see other sources)
Primary Lung Cancer
Staging: T - location (3 cm cutoff)

N - nodes involved

M - metastases (brain, bone, liver)
CXR: concave (good), convex (bad)
Smokers (85%)

squamous, small cell, adenocarcinoma, large cell


Non-smokers (15%)

⅔ are adenocarcinoma (even most adenocarcinomas are from smoking), bronchoalveolar adenoma, other


Central  squamous, small cell, adenocarcinoma (↓)

Peripheral  large cell, adenocarcinoma (↑)
Pattern of spread

all types also commonly spread via the lymphatics / large cell also more through bloodstream


Bronchogenic Carcinomas (SCLC vs. NSCLC)

divided into small cell and non-small cell (adenocarcinoma, large cell, squamous cell)



Note: treatment is chemotherapy and/or radiation for SLCL (rarely surgery) and resection (if possible) and/or chemo for NSCLC / 10% of NSCLC develop some form of HOA (Pierre-Marie-Bamberger syndrome) [pic]
Small Cell Carcinoma (SCC) (20%) – central

oat cell / metastases / smoking / often secrete ectopic hormones (SIADH, ACTH) causing symptoms of hypokalemia (ACTH) or hyponatremia (ADH) / hemoptysis uncommon

Associations: Lambert-Eaton syndrome

Treatment: chemotherapy (not resectable) / 20% can be cured if caught very early


Squamous Cell Carcinoma (30%) – central

metastasis uncommon / smoking / PTH-related (PTHrP) hypercalcemia / HOA with clubbing


Adenocarcinoma (35%) – peripheral > central

characteristic HOA w/ clubbing / makes up 70% of lung cancers in non-smokers


Large Cell (10%) – peripheral

smoking / usually spreading through the bloodstream


Bronchoalveolar adenomaperipheral

not associated with smoking / multifocal origin but often does not extend beyond the lungs / watery, profuse, blood-streaked hemoptysis


Bronchial carcinoid (5%)

benign or malignant / male = female



Complications: may obstruct lumen, frequent bleeding, recurrent pneumonia, pleural pain / carcinoid syndrome (3%)

Course: prolonged / mets (uncommonly) to regional lymph nodes



Pancoast tumor


refers to an apical carcinoma causing pancoast syndrome
Other Lung Tumors
Lymphoma – usually solitary, can be multifocal

Sarcoma – malignant

Carcinosarcoma

Kaposi’s sarcoma (see HIV)

Adenoid cystic .5%

Mucoepidermoid carcinoma .2%

Malignant fibrous histiocytoma

Melanoma

Blastoma


Mucoepidermal

Angiomas – may regress

Squamous papillomatosis – often recur
Benign Tumors
Chondromatous hamartoma

“popcorn” or “bull’s eye” pattern of calcification / cartilage, connective tissue, epithelium



Sclerosing hemangioma

80% female / calcification on X-ray / blood spaces


Horner’s syndrome

invasion of the cervical thoracic sympathetic nerves (paravertebral stellate ganglion) (often by lung cancer)



Findings: enophthalmos, miosis, ptosis, ipsilateral facial anhidrosis, narrowing of palpedral fissure [pic][pic][pic]

Ddx: brainstem or posterior circulation CVA, carotid artery dissection, cavernous sinus thrombosis, trauma, metastatic disease
Pancoast syndrome

infiltration of brachial plexus and neighboring ribs and vertebrae, may involve phrenic nerve / Findings: pain, numbness, and weakness of the affected arm and/or Horner’s syndrome (see above)


Superior vena cava syndrome (SVC syndrome or SVCS)

obstruction of venous drainage  dilation of collateral veins in upper chest, neck  edema and plethora of face, neck, upper part of the torso, including the breasts; suffusion and edema of the conjunctiva; breathlessness when supine; CNS symptoms (headache, visual distortion, ΔMS, dizziness, syncope); dysphagia, hoarseness



Causes: lung cancer (small cell, squamous cell), other malignant neoplasms (lymphoma, Hodgkin’s disease, small cell carcinoma, squamous cell carcinoma, germ cell tumors, and breast cancer), TB, fungal infections, retrosternal thyroid, aortic aneurysms, fibrosing mediastinitis, benign tumors

Treatment: if airway impaired, may need urgent bronchoscopy with stenting, surgical consultation / if lymphoma strongly suspected, may begin steroids even before tissue diagnosis
Hematogenous metastatic spread to the liver, brain, adrenals, and bone
Paraneoplastic syndromes
hypertrophic pulmonary osteoarthropathy (the best known), clubbing of the fingers and toes and periosteal elevation of the distal parts of long bones occur. All levels of the nervous system may be affected--principally causing encephalopathy, subacute cerebellar degeneration, encephalomyelitis, the
CNS paraneoplastic

  • 60% become symptomatic (CNS-wise) wise before any symptoms from primary tumor occur

  • can test for variety of antibodies [table]; no specific antibodies are found in 40% (that may change)

  • may use PET scan or MRI to locate mets or primary [MRI] (note can have false positive on axilla of side of injection of tracer material)


Eaton-Lambert syndrome (see other) and peripheral neuropathy
Paraneoplastic cerebellar degeneration [NEJM]

may present as progressive cerebellar ataxia [table] / 20% have mild memory and cognitive impairment (paraneoplastic limbic encephalitis), new onset seizures (complex partial)

Associated malignancies: small cell lung cancer > breast, ovarian, testicular, Hodgkin’s

MRI: patchy increased T2 without enhancement on T1 distinguishes from brain tumor, other / Purkinje cell dropout in cerebellum shows as atrophy

EEG: focal temporal sharp waves

Labs:


  • antineuronal nuclear antibody type 1 (ANNA-1, anti-Hu) usu. positive with SCLC

  • anti-Yo seen with breast, ovarian tumors

  • anti-Tr, anti-glutamate receptor antibodies


Polymyositis and dermatomyositis

metabolic syndromes due to production of substances with hormonal activity


Small cell carcinomas may secrete ectopic ACTH, resulting in Cushing’s syndrome, or ADH, causing water retention and hyponatremia, and are also associated with the carcinoid syndrome (flushing, wheezing, diarrhea, and cardiac valvular lesions).
Squamous cell carcinomas may secrete parathyroid hormone-like substances that produce hypercalcemia. Other endocrine syndromes associated with primary lung carcinomas include gynecomastia, hyperglycemia, thyrotoxicosis, and skin pigmentation. Hematologic disorders, including thrombocytopenic purpura, leukemoid reaction, myelophthisic anemia, polycythemia, and marantic thrombosis, may also occur.
Findings: gynecomastia, skin pigmentation

Other associations: thyrotoxicosis, TTP, leukemoid reaction, polycythemia, myelophthisic anemia


Single Pulmonary Nodule (SPN)

50% (< 3 cm) prove malignant / coin lesion without surrounding atelectasis or adenopathy



Benign: 80% infectious granulomas, 10% hamartomas, 10% other

Malignant: > 3 cm is probably malignant; most are bronchogenic carcinoma

Ddx: Coccidioides, Histoplasma, Tb, RA, Wegener’s

Bayesian approach  pre-test risk of malignancy vs. need for early removal / if patient < 35 yrs, non-smoker, can follow radiographically first



Risk factors: age, smoking, hemoptysis, size, edge characteristics on CT, prior malignancy

Other: carcinogens, travel, endemic mycoses, prior lung disease



Guidelines for following: constantly changing; (~4-8 mm seems to be a size parameter below which the optimal frequency of repeat CT is debated)
CXR: size / growth rate / margin: corona radiata (80-90% malignant)

calcification:

laminated or central  granuloma

popcorn  hamartoma

diffuse  benign

eccentric/stippled  malignant

less specific  cavitations [CXR], satellite lesions

CT: more sensitive for other lesions, calcifications, guiding TNAB


  • if thought to be benign ( < 35 yrs, stable for 2 yrs, classic calcification pattern)  repeat CXR q 3 months for 1st yr, q 4-6 mo for 2nd year

  • if thought to be malignant  VATS  frozen  thoracotomy/lobectomy

  • indeterminate (usually will prove malignant)

PET (18FDG PET scanning): has 95% sensitivity, 75% specificity (also good for demonstrating positive nodes) / false negatives more likely with tumors < 1 cm, bronchoalveolar carcinomas, carcinoid tumors / false positives from inflammation

Bronchoscopy (better for central): sensitivity 80% > 3 cm (50% peripheral) / 2-3 cm (40-60% yield) / < 1.5 cm (10% yield)

Transthoracic needle biopsy (better for peripheral): 80-95% sensitivity, 50-85% specificity; better than bronchoscopy for peripheral lesions


Download 3.95 Mb.

Share with your friends:
1   ...   20   21   22   23   24   25   26   27   ...   73




The database is protected by copyright ©ininet.org 2024
send message

    Main page